/Companies

Oria Bioscience

Paris, FR · Founded 2024 · 21 employees on LinkedIn · 1 known investors

Find your way into Oria Bioscience

183 people in our graph share verified history with the Oria Bioscience team — schools, employers, funds. One of them is your warm intro.

ORIA is a Paris-based company, spun off from ENS Paris in 2022, that uses a proprietary mechanical microfluidic platform to extract intact, high-purity functional organelles at industrial scale. Its organelle products serve pharmaceutical companies, biotech firms, and academic institutions for drug discovery, disease modeling, and therapeutic research.

Founders & leadership

Oria Bioscience was founded in 2024 by Alexandre SANTINHO and Abdou Rachid THIAM.

ASAlexandre SANTINHO
Alexandre SANTINHOCEOAlexandre Santinho is co-founder and CEO of Oria Bioscience, a Paris-based organelle extraction company spun off from ENS Paris in 2022 that develops microfluidic platforms for drug discovery and biomedical research.
ARAbdou Rachid THIAM
Abdou Rachid THIAMCSO – Scientific Advisor
MM
Marine MOUTIACOO

Investors · 1

In the news

Frequently asked questions

What does Oria Bioscience do?
ORIA is a Paris-based company, spun off from ENS Paris in 2022, that uses a proprietary mechanical microfluidic platform to extract intact, high-purity functional organelles at industrial scale. Its organelle products serve pharmaceutical companies, biotech firms, and academic institutions for drug discovery, disease modeling, and therapeutic research.
Who founded Oria Bioscience?
Oria Bioscience was founded by Alexandre SANTINHO, Abdou Rachid THIAM in 2024.
Who are Oria Bioscience's investors?
Oria Bioscience's investors include Newfund Capital.
Where is Oria Bioscience headquartered?
Oria Bioscience is headquartered in Paris, FR.